No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
Allo-hmscs |
- |
- |
- |
- |
2件: 211, 299 |
2 |
Ambrisentan |
Ambrisentan |
D07077 |
1件: EDNRA |
7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
6件: 51, 84, 85, 86, 88, 211 |
3 |
Autologous (self) mononuclear cells derived from umbilical cord blood |
- |
- |
- |
- |
1件: 211 |
4 |
Autologous cell-based delivery |
- |
- |
- |
- |
1件: 211 |
5 |
Autologous human placental cord blood mononuclear cells |
- |
- |
- |
- |
1件: 211 |
6 |
Autologous umbilical cord blood |
- |
- |
- |
- |
2件: 211, 294 |
7 |
C-kit+ cells |
- |
- |
- |
- |
1件: 211 |
8 |
Erythropoetin |
- |
- |
- |
- |
1件: 211 |
9 |
Longeveron mesenchymal stem cells |
- |
- |
- |
- |
1件: 211 |
10 |
Maternal hyperoxygenation |
- |
- |
- |
- |
1件: 211 |
11 |
Nitrogen |
Nitrogen |
D00083 |
- |
- |
5件: 5, 6, 17, 211, 299 |
12 |
Normal saline |
- |
- |
- |
- |
14件: 6, 17, 22, 36, 46, 49, 60, 94, 96, 211, 226, 276, 296, 299 |
13 |
Oxandrolone |
Oxandrolone |
D00462 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
2件: 211, 285 |
14 |
Sildenafil |
Sildenafil |
D02229, D08514 |
1件: PDE5A |
3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
15件: 6, 46, 50, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
15 |
Tracleer |
Bosentan |
D01227, D07538 |
2件: EDNRA, EDNRB |
9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
8件: 13, 51, 84, 85, 86, 88, 210, 211 |
16 |
Vitamin c |
Ascorbic acid |
D00018 |
- |
- |
5件: 10, 192, 206, 211, 212 |